世界の腫瘍塞栓市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tumor Embolization Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4989 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、腫瘍塞栓の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肝動脈塞栓術（TAE）、薬剤溶出性ビーズ化学塞栓術（DEB-TACE）、放射線塞栓術（RE）、その他）、用途別市場規模（病院、外科医院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腫瘍塞栓の市場動向 ・企業の競争状況、市場シェア ・腫瘍塞栓の種類別市場規模と予測2016-2027（肝動脈塞栓術（TAE）、薬剤溶出性ビーズ化学塞栓術（DEB-TACE）、放射線塞栓術（RE）、その他） ・腫瘍塞栓の用途別市場規模と予測2016-2027（病院、外科医院、専門クリニック、その他） ・腫瘍塞栓の北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍塞栓の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍塞栓のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍塞栓の中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍塞栓の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boston Scientific Corporation、Varian Medical Systems, Inc.、Nordion (Sotera Health)、Sirtex Medical） ・結論

Market Analysis and Insights: Global Tumor Embolization Market
The global Tumor Embolization market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Embolization market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Embolization market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Embolization market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Embolization market.

Global Tumor Embolization Scope and Market Size
Tumor Embolization market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Embolization market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Trans-Arterial Embolization (TAE)
Drug-Eluting Bead Chemoembolization (DEB-TACE)
Radioembolization (RE)
Others

Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boston Scientific Corporation
Varian Medical Systems, Inc.
Nordion (Sotera Health)
Sirtex Medical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Embolization Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Trans-Arterial Embolization (TAE)
1.2.3 Drug-Eluting Bead Chemoembolization (DEB-TACE)
1.2.4 Radioembolization (RE)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tumor Embolization Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tumor Embolization Market Perspective (2016-2027)
2.2 Tumor Embolization Growth Trends by Regions
2.2.1 Tumor Embolization Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tumor Embolization Historic Market Share by Regions (2016-2021)
2.2.3 Tumor Embolization Forecasted Market Size by Regions (2022-2027)
2.3 Tumor Embolization Industry Dynamic
2.3.1 Tumor Embolization Market Trends
2.3.2 Tumor Embolization Market Drivers
2.3.3 Tumor Embolization Market Challenges
2.3.4 Tumor Embolization Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tumor Embolization Players by Revenue
3.1.1 Global Top Tumor Embolization Players by Revenue (2016-2021)
3.1.2 Global Tumor Embolization Revenue Market Share by Players (2016-2021)
3.2 Global Tumor Embolization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tumor Embolization Revenue
3.4 Global Tumor Embolization Market Concentration Ratio
3.4.1 Global Tumor Embolization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Embolization Revenue in 2020
3.5 Tumor Embolization Key Players Head office and Area Served
3.6 Key Players Tumor Embolization Product Solution and Service
3.7 Date of Enter into Tumor Embolization Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Embolization Breakdown Data by Type
4.1 Global Tumor Embolization Historic Market Size by Type (2016-2021)
4.2 Global Tumor Embolization Forecasted Market Size by Type (2022-2027)

5 Tumor Embolization Breakdown Data by Application
5.1 Global Tumor Embolization Historic Market Size by Application (2016-2021)
5.2 Global Tumor Embolization Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tumor Embolization Market Size (2016-2027)
6.2 North America Tumor Embolization Market Size by Type
6.2.1 North America Tumor Embolization Market Size by Type (2016-2021)
6.2.2 North America Tumor Embolization Market Size by Type (2022-2027)
6.2.3 North America Tumor Embolization Market Size by Type (2016-2027)
6.3 North America Tumor Embolization Market Size by Application
6.3.1 North America Tumor Embolization Market Size by Application (2016-2021)
6.3.2 North America Tumor Embolization Market Size by Application (2022-2027)
6.3.3 North America Tumor Embolization Market Size by Application (2016-2027)
6.4 North America Tumor Embolization Market Size by Country
6.4.1 North America Tumor Embolization Market Size by Country (2016-2021)
6.4.2 North America Tumor Embolization Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tumor Embolization Market Size (2016-2027)
7.2 Europe Tumor Embolization Market Size by Type
7.2.1 Europe Tumor Embolization Market Size by Type (2016-2021)
7.2.2 Europe Tumor Embolization Market Size by Type (2022-2027)
7.2.3 Europe Tumor Embolization Market Size by Type (2016-2027)
7.3 Europe Tumor Embolization Market Size by Application
7.3.1 Europe Tumor Embolization Market Size by Application (2016-2021)
7.3.2 Europe Tumor Embolization Market Size by Application (2022-2027)
7.3.3 Europe Tumor Embolization Market Size by Application (2016-2027)
7.4 Europe Tumor Embolization Market Size by Country
7.4.1 Europe Tumor Embolization Market Size by Country (2016-2021)
7.4.2 Europe Tumor Embolization Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tumor Embolization Market Size (2016-2027)
8.2 Asia-Pacific Tumor Embolization Market Size by Type
8.2.1 Asia-Pacific Tumor Embolization Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tumor Embolization Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tumor Embolization Market Size by Type (2016-2027)
8.3 Asia-Pacific Tumor Embolization Market Size by Application
8.3.1 Asia-Pacific Tumor Embolization Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tumor Embolization Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tumor Embolization Market Size by Application (2016-2027)
8.4 Asia-Pacific Tumor Embolization Market Size by Region
8.4.1 Asia-Pacific Tumor Embolization Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tumor Embolization Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tumor Embolization Market Size (2016-2027)
9.2 Latin America Tumor Embolization Market Size by Type
9.2.1 Latin America Tumor Embolization Market Size by Type (2016-2021)
9.2.2 Latin America Tumor Embolization Market Size by Type (2022-2027)
9.2.3 Latin America Tumor Embolization Market Size by Type (2016-2027)
9.3 Latin America Tumor Embolization Market Size by Application
9.3.1 Latin America Tumor Embolization Market Size by Application (2016-2021)
9.3.2 Latin America Tumor Embolization Market Size by Application (2022-2027)
9.3.3 Latin America Tumor Embolization Market Size by Application (2016-2027)
9.4 Latin America Tumor Embolization Market Size by Country
9.4.1 Latin America Tumor Embolization Market Size by Country (2016-2021)
9.4.2 Latin America Tumor Embolization Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tumor Embolization Market Size (2016-2027)
10.2 Middle East & Africa Tumor Embolization Market Size by Type
10.2.1 Middle East & Africa Tumor Embolization Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tumor Embolization Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tumor Embolization Market Size by Type (2016-2027)
10.3 Middle East & Africa Tumor Embolization Market Size by Application
10.3.1 Middle East & Africa Tumor Embolization Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tumor Embolization Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tumor Embolization Market Size by Application (2016-2027)
10.4 Middle East & Africa Tumor Embolization Market Size by Country
10.4.1 Middle East & Africa Tumor Embolization Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tumor Embolization Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Details
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Tumor Embolization Introduction
11.1.4 Boston Scientific Corporation Revenue in Tumor Embolization Business (2016-2021)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Varian Medical Systems, Inc.
11.2.1 Varian Medical Systems, Inc. Company Details
11.2.2 Varian Medical Systems, Inc. Business Overview
11.2.3 Varian Medical Systems, Inc. Tumor Embolization Introduction
11.2.4 Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2016-2021)
11.2.5 Varian Medical Systems, Inc. Recent Development
11.3 Nordion (Sotera Health)
11.3.1 Nordion (Sotera Health) Company Details
11.3.2 Nordion (Sotera Health) Business Overview
11.3.3 Nordion (Sotera Health) Tumor Embolization Introduction
11.3.4 Nordion (Sotera Health) Revenue in Tumor Embolization Business (2016-2021)
11.3.5 Nordion (Sotera Health) Recent Development
11.4 Sirtex Medical
11.4.1 Sirtex Medical Company Details
11.4.2 Sirtex Medical Business Overview
11.4.3 Sirtex Medical Tumor Embolization Introduction
11.4.4 Sirtex Medical Revenue in Tumor Embolization Business (2016-2021)
11.4.5 Sirtex Medical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tumor Embolization Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Trans-Arterial Embolization (TAE)
Table 3. Key Players of Drug-Eluting Bead Chemoembolization (DEB-TACE)
Table 4. Key Players of Radioembolization (RE)
Table 5. Key Players of Others
Table 6. Global Tumor Embolization Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Tumor Embolization Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Tumor Embolization Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Tumor Embolization Market Share by Regions (2016-2021)
Table 10. Global Tumor Embolization Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Tumor Embolization Market Share by Regions (2022-2027)
Table 12. Tumor Embolization Market Trends
Table 13. Tumor Embolization Market Drivers
Table 14. Tumor Embolization Market Challenges
Table 15. Tumor Embolization Market Restraints
Table 16. Global Tumor Embolization Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Tumor Embolization Market Share by Players (2016-2021)
Table 18. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Embolization as of 2020)
Table 19. Ranking of Global Top Tumor Embolization Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Tumor Embolization Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Tumor Embolization Product Solution and Service
Table 23. Date of Enter into Tumor Embolization Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Tumor Embolization Revenue Market Share by Type (2016-2021)
Table 27. Global Tumor Embolization Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Tumor Embolization Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Tumor Embolization Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Tumor Embolization Revenue Market Share by Application (2016-2021)
Table 31. Global Tumor Embolization Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Tumor Embolization Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Tumor Embolization Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Tumor Embolization Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Tumor Embolization Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Tumor Embolization Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Tumor Embolization Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Tumor Embolization Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Tumor Embolization Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Tumor Embolization Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Tumor Embolization Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Tumor Embolization Market Size by Country (2022-2027) & (US$ Million)
Table 63. Boston Scientific Corporation Company Details
Table 64. Boston Scientific Corporation Business Overview
Table 65. Boston Scientific Corporation Tumor Embolization Product
Table 66. Boston Scientific Corporation Revenue in Tumor Embolization Business (2016-2021) & (US$ Million)
Table 67. Boston Scientific Corporation Recent Development
Table 68. Varian Medical Systems, Inc. Company Details
Table 69. Varian Medical Systems, Inc. Business Overview
Table 70. Varian Medical Systems, Inc. Tumor Embolization Product
Table 71. Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2016-2021) & (US$ Million)
Table 72. Varian Medical Systems, Inc. Recent Development
Table 73. Nordion (Sotera Health) Company Details
Table 74. Nordion (Sotera Health) Business Overview
Table 75. Nordion (Sotera Health) Tumor Embolization Product
Table 76. Nordion (Sotera Health) Revenue in Tumor Embolization Business (2016-2021) & (US$ Million)
Table 77. Nordion (Sotera Health) Recent Development
Table 78. Sirtex Medical Company Details
Table 79. Sirtex Medical Business Overview
Table 80. Sirtex Medical Tumor Embolization Product
Table 81. Sirtex Medical Revenue in Tumor Embolization Business (2016-2021) & (US$ Million)
Table 82. Sirtex Medical Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Embolization Market Share by Type: 2020 VS 2027
Figure 2. Trans-Arterial Embolization (TAE) Features
Figure 3. Drug-Eluting Bead Chemoembolization (DEB-TACE) Features
Figure 4. Radioembolization (RE) Features
Figure 5. Others Features
Figure 6. Global Tumor Embolization Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Tumor Embolization Report Years Considered
Figure 12. Global Tumor Embolization Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Tumor Embolization Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Tumor Embolization Market Share by Regions: 2020 VS 2027
Figure 15. Global Tumor Embolization Market Share by Regions (2022-2027)
Figure 16. Global Tumor Embolization Market Share by Players in 2020
Figure 17. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Embolization as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Tumor Embolization Revenue in 2020
Figure 19. Global Tumor Embolization Revenue Market Share by Type (2016-2021)
Figure 20. Global Tumor Embolization Revenue Market Share by Type (2022-2027)
Figure 21. North America Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Tumor Embolization Market Share by Type (2016-2027)
Figure 23. North America Tumor Embolization Market Share by Application (2016-2027)
Figure 24. North America Tumor Embolization Market Share by Country (2016-2027)
Figure 25. United States Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Tumor Embolization Market Share by Type (2016-2027)
Figure 29. Europe Tumor Embolization Market Share by Application (2016-2027)
Figure 30. Europe Tumor Embolization Market Share by Country (2016-2027)
Figure 31. Germany Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Tumor Embolization Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Tumor Embolization Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Tumor Embolization Market Share by Region (2016-2027)
Figure 41. China Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Tumor Embolization Market Share by Type (2016-2027)
Figure 49. Latin America Tumor Embolization Market Share by Application (2016-2027)
Figure 50. Latin America Tumor Embolization Market Share by Country (2016-2027)
Figure 51. Mexico Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Tumor Embolization Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Tumor Embolization Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Tumor Embolization Market Share by Country (2016-2027)
Figure 57. Turkey Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Boston Scientific Corporation Revenue Growth Rate in Tumor Embolization Business (2016-2021)
Figure 61. Varian Medical Systems, Inc. Revenue Growth Rate in Tumor Embolization Business (2016-2021)
Figure 62. Nordion (Sotera Health) Revenue Growth Rate in Tumor Embolization Business (2016-2021)
Figure 63. Sirtex Medical Revenue Growth Rate in Tumor Embolization Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---